Heart health articles for people with diabetes, including blood pressure, cholesterol, kidney overlap, medicines, activity, food choices, and cardiovascular risk.Seek urgent care for chest pain, severe shortness of breath, stroke warning signs, fainting, or symptoms that feel dangerous.
A post hoc CANVAS analysis found no clear kidney or cardiovascular advantage for canagliflozin 300 mg over 100 mg, but the findings are hypothesis-generating rather than definitive.
A prespecified VESALIUS-CV analysis found fewer major cardiovascular events with evolocumab in selected adults with high-risk diabetes, but the results are not a recommendation for everyone with diabetes.
A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across cardiovascular-risk groups in adults with type 2 diabetes and chronic kidney disease.
